| RS1487432642 |
OTOF
|
Health Risk |
Pathogenic/Likely pathogenic |
Bilateral sensorineural hearing impairment, Bilateral sensorineural hearing impairment |
| RS1487432916 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS148743316 |
LOXL3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148744436 |
KANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
KANK1-related disorder, KANK1-related disorder |
| RS1487446205 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1487450999 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS148745414 |
ARL6
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 55, Bardet-Biedl syndrome 3 |
| RS148745997 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Autoinflammatory syndrome |
| RS148746224 |
ZSWIM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1487466505 |
PPM1D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148747022 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS1487476449 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1487477220 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS1487483670 |
PRIM1
|
Health Risk |
Pathogenic |
Primordial dwarfism-immunodeficiency-lipodystrophy syndrome, Seckel syndrome |
| RS148748724 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, MCOLN1-related disorder |
| RS148748781 |
RHO
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1487490244 |
POT1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Tumor predisposition syndrome 3 |
| RS1487491068 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS148749290 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS148749736 |
ARSH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148749888 |
SCNN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism, type IB1 |
| RS148749994 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, KIF7-related disorder |
| RS1487503835 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS148751867 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS1487519669 |
CCBE1
|
Health Risk |
Likely pathogenic |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS148752066 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS148752234 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schimke immuno-osseous dysplasia, SMARCAL1-related disorder |
| RS148752352 |
CLRN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 3, Usher syndrome type 3A |
| RS148752831 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Budd-Chiari syndrome, Factor V deficiency |
| RS1487531695 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS148753593 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Regional enteritis |
| RS1487540503 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 38, Retinitis pigmentosa 38 |
| RS1487548809 |
CFAP20
|
Health Risk |
Likely pathogenic |
Rod-cone dystrophy, Rod-cone dystrophy |
| RS1487550618 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS148755083 |
IL36RN
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized pustular psoriasis, Autoinflammatory syndrome |
| RS1487555931 |
TULP1
|
Health Risk |
Pathogenic |
— |
| RS148755655 |
UGT1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gilbert syndrome, Crigler-Najjar syndrome |
| RS148756522 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Isolated focal cortical dysplasia type II |
| RS1487568635 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1487577386 |
WNT10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Tooth agenesis, selective |
| RS148758785 |
PDHX
|
Health Risk |
Conflicting classifications of pathogenicity |
PDHX-related disorder, PDHX-related disorder |
| RS148758906 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS1487589344 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS148759214 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type I |
| RS148759919 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2P, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS148759949 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS148761230 |
COL17A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS148763371 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Progressive familial heart block type IB |
| RS1487638242 |
COL6A2
|
Health Risk |
Likely pathogenic |
— |
| RS148764188 |
ODAD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia |
| RS148764264 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS148764840 |
GJC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS148765149 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1487660277 |
GDF1
|
Health Risk |
Pathogenic |
— |
| RS1487665337 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS148766950 |
DMXL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DMXL2-related disorder |
| RS1487673182 |
PLD1
|
Health Risk |
Likely pathogenic |
Cardiac valvular defect, developmental |
| RS148767682 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1487680236 |
MUSK
|
Health Risk |
Pathogenic/Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS1487693460 |
CC2D2A
|
Health Risk |
Likely pathogenic |
— |
| RS148770294 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS148770452 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS148770543 |
MFAP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, MFAP5-related disorder |
| RS148770948 |
ARFGEF2
|
Health Risk |
Conflicting classifications of pathogenicity |
ARFGEF2-related disorder, Periventricular heterotopia with microcephaly |
| RS1487715574 |
WFS1
|
Health Risk |
Pathogenic |
— |
| RS148772659 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Budd-Chiari syndrome, Factor V deficiency |
| RS148773718 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Inborn genetic diseases |
| RS1487742962 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS148774506 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Isolated cryptophthalmia |
| RS148774882 |
SEMA5A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148775168 |
STAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 31B, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS148775220 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1487757753 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS148776624 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
Moyamoya disease 2, See cases |
| RS148776783 |
SCNN1G
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148777544 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS1487775766 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148778122 |
PTH1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary failure of tooth eruption, Eiken syndrome |
| RS1487781332 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148778319 |
GRHPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type II |
| RS148778436 |
ALDH4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS148778842 |
APOA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1487802284 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS1487803250 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia |
| RS1487808056 |
SRD5A3
|
Health Risk |
Pathogenic |
— |
| RS1487809821 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS148781346 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS1487813766 |
PGAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148781420 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A1-related disorder, Brain small vessel disease 1 with or without ocular anomalies |
| RS1487814687 |
DSP
|
Health Risk |
Pathogenic |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS148782148 |
PKP4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148782406 |
BIVM-ERCC5;ERCC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group G |
| RS148782717 |
TYRP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 3, Oculocutaneous albinism type 3 |
| RS148782895 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS148783445 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS1487834487 |
MMP21
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1487836380 |
ATP2B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS148784027 |
MPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1487842051 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS148784343 |
PNPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxal phosphate-responsive seizures, Inborn genetic diseases |